SURGERY PARTNERS INC (SGRY) Stock Analyst Earnings Estimates
NASDAQ:SGRY - Nasdaq - US86881A1007 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.539B 14.12% | 2.743B 8.03% | 3.114B 13.52% | 3.443B 10.55% | 3.76B 9.21% | 4.143B 10.19% | 4.615B 11.39% | 5.087B 10.23% | |
| EBITDA YoY % growth | 489.3M 21.44% | 533M 8.93% | 626.9M 17.62% | 571.55M -8.83% | 639.75M 11.93% | 721.81M 12.83% | N/A | N/A | |
| EBIT YoY % growth | 374.5M 23.15% | 414.9M 10.79% | 474.3M 14.32% | 460.49M -2.91% | 528.69M 14.81% | 542.01M 2.52% | N/A | N/A | |
| Operating Margin | 14.75% | 15.12% | 15.23% | 13.37% | 14.06% | 13.08% | N/A | N/A | |
| EPS YoY % growth | 0.13 208.33% | 0.99 661.54% | 0.94 -5.05% | 0.90 -4.47% | 1.13 26.17% | 1.37 21.07% | 2.17 58.39% | 2.65 22.07% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.24 25.23% | 0.48 8.01% | 0.07 71.21% | 0.25 44.36% | 0.33 38.98% | 0.60 26.67% |
| Revenue Q2Q % growth | 851.03M 10.47% | 967.43M 11.92% | 872.75M 12.47% | 933.32M 12.97% | 955.64M 12.29% | 1.004B 3.78% |
| EBITDA Q2Q % growth | 145.87M -33.39% | 188.88M -41.99% | 116.9M -7.15% | 150.69M 15.12% | 167.26M 14.66% | 205.93M 9.03% |
| EBIT Q2Q % growth | 118.2M 17.85% | 172.18M -0.47% | 88.241M -1.52% | 99.654M -5.72% | 111.68M -5.52% | 153.65M -10.76% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.17 -19.05% | 0.14 | 0.03 | 24.15% |
| Q1 2025 Q2Q % growth | 0.04 -60.00% | 0.05 | -0.01 | -24.34% |
| Q4 2024 Q2Q % growth | 0.44 | 0.38 | 0.06 | 14.96% |
| Q3 2024 Q2Q % growth | 0.19 | 0.26 | -0.07 | -26.04% |
| Q2 2024 Q2Q % growth | 0.21 -25.00% | 0.20 | 0.01 | 2.99% |
| Q1 2024 Q2Q % growth | 0.10 25.00% | 0.07 | 0.03 | 37.02% |
| Q4 2023 Q2Q % growth | 0.44 62.96% | 0.39 | 0.05 | 13.88% |
| Q3 2023 Q2Q % growth | 0.19 1,050.00% | 0.17 | 0.02 | 14.21% |
| Q2 2023 Q2Q % growth | 0.28 1,033.33% | 0.08 | 0.20 | 238.52% |
| Q1 2023 Q2Q % growth | 0.08 188.89% | 0.00 | 0.08 | 1,911.06% |
| Q4 2022 Q2Q % growth | 0.27 17.39% | 0.19 | 0.08 | 43.08% |
| Q3 2022 Q2Q % growth | -0.02 60.00% | 0.05 | -0.07 | -142.97% |
| Q2 2022 Q2Q % growth | -0.03 | -0.01 | -0.02 | -335.73% |
| Q1 2022 Q2Q % growth | -0.09 70.00% | -0.06 | -0.03 | -44.65% |
| Q4 2021 Q2Q % growth | 0.23 155.56% | 0.20 | 0.03 | 16.36% |
| Q3 2021 Q2Q % growth | -0.05 90.57% | -0.11 | 0.06 | 53.04% |
| Q2 2021 Q2Q % growth | 0.00 100.00% | -0.19 | 0.19 | 100.00% |
| Q1 2021 Q2Q % growth | -0.30 11.76% | -0.38 | 0.08 | 20.78% |
| Q4 2020 Q2Q % growth | 0.09 -10.00% | 0.02 | 0.07 | 445.67% |
| Q3 2020 Q2Q % growth | -0.53 -89.29% | -0.39 | -0.14 | -37.24% |
| Q2 2020 Q2Q % growth | -1.36 -368.97% | -0.71 | -0.65 | -92.77% |
| Q1 2020 Q2Q % growth | -0.34 19.05% | -0.49 | 0.15 | 30.90% |
| Q4 2019 Q2Q % growth | 0.10 | 0.13 | -0.03 | -20.94% |
| Q3 2019 Q2Q % growth | -0.28 | -0.25 | -0.03 | -12.81% |
| Q2 2019 Q2Q % growth | -0.29 | -0.18 | -0.11 | -64.58% |
| Q1 2019 Q2Q % growth | -0.42 | -0.28 | -0.14 | -49.43% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 826.2M 8.41% | 833.31M | -7.11M | -0.85% |
| Q1 2025 Q2Q % growth | 776M 8.17% | 792.63M | -16.63M | -2.10% |
| Q4 2024 Q2Q % growth | 864.4M 17.54% | 844.66M | 19.74M | 2.34% |
| Q3 2024 Q2Q % growth | 770.4M 14.29% | 785.16M | -14.76M | -1.88% |
| Q2 2024 Q2Q % growth | 762.1M 14.16% | 750.28M | 11.82M | 1.58% |
| Q1 2024 Q2Q % growth | 717.4M 7.69% | 712.19M | 5.21M | 0.73% |
| Q4 2023 Q2Q % growth | 735.4M 4.00% | 756.34M | -20.94M | -2.77% |
| Q3 2023 Q2Q % growth | 674.1M 8.62% | 685.72M | -11.62M | -1.69% |
| Q2 2023 Q2Q % growth | 667.6M 8.48% | 681.74M | -14.14M | -2.07% |
| Q1 2023 Q2Q % growth | 666.2M 11.74% | 670.24M | -4.04M | -0.60% |
| Q4 2022 Q2Q % growth | 707.1M 15.88% | 702.47M | 4.63M | 0.66% |
| Q3 2022 Q2Q % growth | 620.6M 10.98% | 647.73M | -27.13M | -4.19% |
| Q2 2022 Q2Q % growth | 615.4M 13.27% | 631.36M | -15.96M | -2.53% |
| Q1 2022 Q2Q % growth | 596.2M 16.35% | 581.26M | 14.94M | 2.57% |
| Q4 2021 Q2Q % growth | 610.2M 11.29% | 634.18M | -23.98M | -3.78% |
| Q3 2021 Q2Q % growth | 559.2M 12.72% | 556.77M | 2.43M | 0.44% |
| Q2 2021 Q2Q % growth | 543.3M 45.00% | 549.07M | -5.77M | -1.05% |
| Q1 2021 Q2Q % growth | 512.4M 16.19% | 509.04M | 3.36M | 0.66% |
| Q4 2020 Q2Q % growth | 548.3M 6.01% | 557.53M | -9.23M | -1.66% |
| Q3 2020 Q2Q % growth | 496.1M 9.76% | 476.78M | 19.32M | 4.05% |
| Q2 2020 Q2Q % growth | 374.7M -15.87% | 348.92M | 25.78M | 7.39% |
| Q1 2020 Q2Q % growth | 441M 5.81% | 404.6M | 36.4M | 9.00% |
| Q4 2019 Q2Q % growth | 517.2M | 524.9M | -7.7M | -1.47% |
| Q3 2019 Q2Q % growth | 452M | 462.19M | -10.19M | -2.20% |
| Q2 2019 Q2Q % growth | 445.4M | 460.45M | -15.05M | -3.27% |
| Q1 2019 Q2Q % growth | 416.8M | 432.08M | -15.28M | -3.54% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.08% | -29.88% | 0% | -13.03% |
| Revenue | 0.14% | 0.11% | 0% | -0.29% |